{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:02:38Z","timestamp":1791068558790,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T00:00:00Z","timestamp":1331596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11926-012-0249-3","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T09:54:48Z","timestamp":1331546088000},"page":"275-285","source":"Crossref","is-referenced-by-count":189,"title":["Morbidity and Mortality in Adult Polymyositis and Dermatomyositis"],"prefix":"10.1007","volume":"14","author":[{"given":"Isabelle","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"249_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","volume":"355","author":"JP Callen","year":"2000","unstructured":"Callen JP. Dermatomyositis. Lancet. 2000;355:53\u20137.","journal-title":"Lancet"},{"key":"249_CR2","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"\u2022\u2022 Marie I, Hatron PY, Dominique S, et al. Short term and long term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum. 2011;63:3439\u201347. This was a multicenter study evaluating both the long-term outcome of and therapy for ILD in 107 PM\/DM patients. This study also looked at the predictive factors for ILD deterioration in PM\/DM.","journal-title":"Arthritis Rheum"},{"key":"249_CR3","first-page":"2706","volume":"26","author":"I Marie","year":"1999","unstructured":"Marie I, Hachulla E, Levesque H, et al. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol. 1999;26:2706\u20139.","journal-title":"J Rheumatol"},{"key":"249_CR4","first-page":"2230","volume":"28","author":"I Marie","year":"2001","unstructured":"Marie I, Hachulla E, Hatron PY, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors. J Rheumatol. 2001;28:2230\u20137.","journal-title":"J Rheumatol"},{"key":"249_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","volume":"78","author":"I Marie","year":"1999","unstructured":"Marie I, Hatron PY, Levesque H, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore). 1999;78:139\u201347.","journal-title":"Medicine (Baltimore)"},{"key":"249_CR6","doi-asserted-by":"crossref","unstructured":"\u2022 Marie I, Josse S, Decaux O, et al. Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev. 2012. doi: 10.1016\/j.autrev.2012.01.006 . This multicenter study underlines that anti\u2013Jo1-positive patients more often experience severe myositis and joint manifestations; on the other hand, anti\u2013PL7\/PL12-positive patients more commonly exhibit early and severe ILD and gastrointestinal complications.","DOI":"10.1016\/j.autrev.2012.01.006"},{"key":"249_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","volume":"162","author":"I Marie","year":"2010","unstructured":"Marie I, Lahaxe L, Benveniste O, et al. Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010;162:337\u201344.","journal-title":"Br J Dermatol"},{"key":"249_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","volume":"41","author":"I Marie","year":"2011","unstructured":"\u2022\u2022 Marie I, M\u00e9nard JF, Hachulla E, et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum. 2011;41:48\u201360. This multicenter study presented the prevalence and characteristics of nonopportunistic\/opportunistic infections in PM\/DM. The authors further identified the risk factors for infections in PM\/DM patients.","journal-title":"Semin Arthritis Rheum"},{"key":"249_CR9","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.20325","volume":"62","author":"I Marie","year":"2010","unstructured":"Marie I, Menard JF, Hatron PY, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010;62:1748\u201355.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"249_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.autrev.2011.06.007","volume":"11","author":"I Marie","year":"2011","unstructured":"Marie I, Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmun Rev. 2011;11:6\u201313.","journal-title":"Autoimmun Rev"},{"key":"249_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"249_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med"},{"key":"249_CR13","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest. 1996;97:2905\u201310.","journal-title":"J Clin Invest"},{"key":"249_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","volume":"6","author":"MC Dalakas","year":"2010","unstructured":"Dalakas MC. Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010;6:129\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"249_CR15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archderm.1940.01490120003001","volume":"41","author":"PA O\u2019Leary","year":"1940","unstructured":"O\u2019Leary PA, Waisman M. Dermatomyositis: a study of 40 cases. Arch Dermatol Syphil. 1940;41:1001\u201319.","journal-title":"Arch Dermatol Syphil"},{"key":"249_CR16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/89.4.747","volume":"89","author":"AL Rose","year":"1966","unstructured":"Rose AL, Walton JN. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain. 1966;89:747\u201368.","journal-title":"Brain"},{"key":"249_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","volume":"25","author":"A Airio","year":"2006","unstructured":"Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol. 2006;25:234\u20139.","journal-title":"Clin Rheumatol"},{"key":"249_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","volume":"28","author":"J Benbassat","year":"1985","unstructured":"Benbassat J, Geffel D, Larholt K, et al. Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. 1985;28:249\u201355.","journal-title":"Arthritis Rheum"},{"key":"249_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","volume":"56","author":"A Bohan","year":"1977","unstructured":"Bohan A, Peter JB, Bowman RL, et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56:255\u201386.","journal-title":"Medicine (Baltimore)"},{"key":"249_CR20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","volume":"65","author":"IM Bronner","year":"2006","unstructured":"Bronner IM, van der Meulen MF, de Visser M, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis. 2006;65:1456\u201361.","journal-title":"Ann Rheum Dis"},{"key":"249_CR21","first-page":"207","volume":"4","author":"JR Carpenter","year":"1977","unstructured":"Carpenter JR, Bunch TW, Engel AG, et al. Survival in polymyositis: corticosteroids and risk factors. J Rheumatol. 1977;4:207\u201314.","journal-title":"J Rheumatol"},{"key":"249_CR22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/brain\/98.4.637","volume":"98","author":"R DeVere","year":"1975","unstructured":"DeVere R, Bradley WG. Polymyositis: its presentation, morbidity and mortality. Brain. 1975;98:637\u201366.","journal-title":"Brain"},{"key":"249_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","volume":"83","author":"K Danko","year":"2004","unstructured":"Danko K, Ponyi A, Constantin T, et al. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore). 2004;83:35\u201342.","journal-title":"Medicine (Baltimore)"},{"key":"249_CR24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1982.tb03087.x","volume":"65","author":"KG Henriksson","year":"1982","unstructured":"Henriksson KG, Sandstedt P. Polymyositis\u2013treatment and prognosis. A study of 107 patients. Acta Neurol Scand. 1982;65:280\u2013300.","journal-title":"Acta Neurol Scand"},{"key":"249_CR25","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.1780261208","volume":"26","author":"MC Hochberg","year":"1983","unstructured":"Hochberg MC, Lopez-Acuna D, Gittelsohn A. Mortality from polymyositis and dermatomyositis in the United States, 1968\u20131978. Arthritis Rheum. 1983;26:1465\u201371.","journal-title":"Arthritis Rheum"},{"key":"249_CR26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","volume":"52","author":"ET Koh","year":"1993","unstructured":"Koh ET, Seow A, Ong B, et al. Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis. 1993;52:857\u201361.","journal-title":"Ann Rheum Dis"},{"key":"249_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1445-5994.2004.00764.x","volume":"35","author":"SJ Lynn","year":"2005","unstructured":"Lynn SJ, Sawyers SM, Moller PW, et al. Adult-onset inflammatory myopathy: North Canterbury experience 1989\u20132001. Int Med J. 2005;35:170\u20133.","journal-title":"Int Med J"},{"key":"249_CR28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","volume":"14","author":"TA Medsger Jr","year":"1971","unstructured":"Medsger Jr TA. Robinson H, Masi AT: Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum. 1971;14:249\u201358.","journal-title":"Arthritis Rheum"},{"key":"249_CR29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10067-010-1465-8","volume":"29","author":"KN Mustafa","year":"2010","unstructured":"Mustafa KN, Dahbour SS. Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996\u20132009. Clin Rheumatol. 2010;29:1381\u20135.","journal-title":"Clin Rheumatol"},{"key":"249_CR30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/ar3704","volume":"14","author":"E Schiopu","year":"2012","unstructured":"\u2022 Schiopu E, Phillips K, Macdonald PM, et al. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate, and azathioprine. Arthritis Res Ther. 2012;14:22. This is the more recent study done in significant numbers of PM\/DM patients. The authors identified therapy as a predictive factor for PM\/DM prognosis. The 5-year survival rate was lower in the initially intravenous corticosteroids\u2013treated patients; the 5- to 10-year survival rate was also found to be higher for the methotrexate-treated patients.","journal-title":"Arthritis Res Ther"},{"key":"249_CR31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, et al. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 2002;41:22\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"249_CR32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08916930600622603","volume":"39","author":"C Torres","year":"2006","unstructured":"Torres C, Belmonte R, Carmona L, et al. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity. 2006;39:205\u201315.","journal-title":"Autoimmunity"},{"key":"249_CR33","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","volume":"38","author":"Y Yamasaki","year":"2011","unstructured":"Yamasaki Y, Yamada H, Ohkubo M, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38:1636\u201343.","journal-title":"J Rheumatol"},{"key":"249_CR34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s10067-011-1840-0","volume":"30","author":"KH Yu","year":"2011","unstructured":"Yu KH, Wu YJ, Kuo CF, et al. Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. Clin Rheumatol. 2011;30:1595\u2013601.","journal-title":"Clin Rheumatol"},{"key":"249_CR35","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Marie I, Hatron PY, Dominique S, et al. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum. 2011. doi: 10.1016\/j.semarthit.2011.09.008 . Association of anti-Ro52 and anti\u2013Jo-1 antibodies in patients with PM\/DM seems to be a poor prognostic factor in PM\/DM. Coexistent anti-Ro52 antibody in anti\u2013Jo-1 positive patients has been shown to be associated with deterioration of myositis\/joint involvement, symptomatic form of ILD, increased risk of cancer, and higher mortality.","DOI":"10.1016\/j.semarthrit.2011.09.008"},{"key":"249_CR36","first-page":"1401","volume":"6","author":"R Queiro-Silva","year":"2001","unstructured":"Queiro-Silva R, Banegil I, Banegil I, de Dios-Jimenez de Aber\u00e1sturi JR, et al. Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis. Expanding the clinical spectrum of the antisynthetase syndrome. J Rheumatol. 2001;6:1401\u20134.","journal-title":"J Rheumatol"},{"key":"249_CR37","first-page":"681","volume":"21","author":"I Marie","year":"2003","unstructured":"Marie I, Fournet P, Janvresse A, et al. Periarticular calcifications and arthropathy as the first manifestation of polymyositis. Clin Exp Rheumatol. 2003;21:681\u20132.","journal-title":"Clin Exp Rheumatol"},{"key":"249_CR38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4065\/82.4.441","volume":"82","author":"TH Oh","year":"2007","unstructured":"Oh TH, Brumfield KA, Hoskin TL, et al. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007;82:441\u20137.","journal-title":"Mayo Clin Proc"},{"key":"249_CR39","first-page":"1336","volume":"25","author":"I Marie","year":"1998","unstructured":"Marie I, Hatron PY, Hachulla E, et al. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 1998;25:1336\u201343.","journal-title":"J Rheumatol"},{"key":"249_CR40","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest. 2010;138:1464\u201374.","journal-title":"Chest"},{"key":"249_CR41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","volume":"28","author":"IJ Chen","year":"2009","unstructured":"Chen IJ, Jan Wu YJ, Lin CW, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol. 2009;28:639\u201346.","journal-title":"Clin Rheumatol"},{"key":"249_CR42","first-page":"809","volume":"22","author":"JT Lie","year":"1995","unstructured":"Lie JT. Cardiac manifestations in polymyositis\/dermatomyositis: how to get to heart of the matter. J Rheumatol. 1995;22:809\u201311.","journal-title":"J Rheumatol"},{"key":"249_CR43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.51.3.378","volume":"51","author":"EC Moore","year":"1992","unstructured":"Moore EC, Cohen F, Douglas SD, et al. Staphylococcal infections in childhood dermatomyositis-association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. Ann Rheum Dis. 1992;51:378\u201383.","journal-title":"Ann Rheum Dis"},{"key":"249_CR44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","volume":"53","author":"I Marie","year":"2005","unstructured":"Marie I, Hachulla E, Ch\u00e9rin P, et al. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum. 2005;53:155\u201365.","journal-title":"Arthritis Rheum"},{"key":"249_CR45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2152\/jmi.54.295","volume":"54","author":"K Tani","year":"2007","unstructured":"Tani K, Tomioka R, Sato K, et al. Comparison of clinical course of polymyositis and dermatomyositis: a follow-up in Tokushima University Hospital. J Med Invest. 2007;54:295\u2013302.","journal-title":"J Med Invest"},{"key":"249_CR46","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/bmj.322.7301.1516","volume":"322","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R, Jolley D, Wyatt M. Population based intervention to change back pain beliefs and disability: three part evaluation. Br Med J. 2001;322:1516\u201320.","journal-title":"Br Med J"},{"key":"249_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","volume":"6","author":"WH Chow","year":"1995","unstructured":"Chow WH, Gridley G, Mellemkjaer L, et al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 1995;6:9\u201313.","journal-title":"Cancer Causes Control"},{"key":"249_CR48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96\u2013100.","journal-title":"Lancet"},{"key":"249_CR49","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","volume":"161","author":"YL Huang","year":"2009","unstructured":"Huang YL, Chen YJ, Lin MW, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol. 2009;161:854\u201360.","journal-title":"Br J Dermatol"},{"key":"249_CR50","doi-asserted-by":"crossref","unstructured":"Marie I, Guillevin L, Menard JF, et al. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev. 2011. doi: 10.1016\/j.autrev.2011.10.024 .","DOI":"10.1016\/j.autrev.2011.10.024"},{"key":"249_CR51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0049-0172(96)80025-4","volume":"26","author":"I Uthman","year":"1996","unstructured":"Uthman I, V\u00e1zquez-Abad D, Sen\u00e9cal JL. Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthritis Rheum. 1996;26:447\u201358.","journal-title":"Semin Arthritis Rheum"},{"key":"249_CR52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780380907","volume":"38","author":"AE Clarke","year":"1995","unstructured":"Clarke AE, Bloch DA, Medsger Jr TA, et al. A longitudinal study of functional disability in a national cohort of patients with polymyositis\/dermatomyositis. Arthritis Rheum. 1995;38:1218\u201324.","journal-title":"Arthritis Rheum"},{"key":"249_CR53","first-page":"263","volume":"14","author":"YM Maugars","year":"1996","unstructured":"Maugars YM, Berthelot JM, Abbas AA, et al. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. 1996;14:263\u201374.","journal-title":"Clin Exp Rheumatol"},{"key":"249_CR54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keh404","volume":"44","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, Borgulya G, Constantin T, et al. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford). 2005;44:83\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"249_CR55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1346-8138.1994.tb01818.x","volume":"21","author":"T Yamamoto","year":"1994","unstructured":"Yamamoto T, Ohkubo H, Katayama I, et al. Dermatomyositis with multiple skin ulcers showing vasculitis and membrano-cystic lesion. J Dermatol. 1994;21:687\u20139.","journal-title":"J Dermatol"},{"key":"249_CR56","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10067-007-0588-z","volume":"26","author":"Y Sherer","year":"2007","unstructured":"Sherer Y, Shepshelovich D, Shalev T, et al. Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol. 2007;26:1851\u20135.","journal-title":"Clin Rheumatol"},{"key":"249_CR57","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70:360\u201374.","journal-title":"Medicine (Baltimore)"},{"key":"249_CR58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"\u2022\u2022 Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147:391\u20138. Two myositis-related antibodies, anti-155\/140 and anti\u2013CADM-140, are associated with a particular phenotype of myositis. Anti-155\/140 antibody is associated with malignancy, whereas the presence of anti\u2013CADM-140 antibody is associated with amyopathic DM and rapidly progressive ILD.","journal-title":"Arch Dermatol"},{"key":"249_CR59","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","volume":"63","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, Drouot L, Jouen F, et al. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011;63:1961\u201371.","journal-title":"Arthritis Rheum"},{"key":"249_CR60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K, Fujimoto M, Hasegawa M, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007;46:25\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"249_CR61","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Mamyrova G, Trieu EP. et al; Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group: A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54:3682\u20139.","journal-title":"Arthritis Rheum"},{"key":"249_CR62","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571\u20136.","journal-title":"Arthritis Rheum"},{"key":"249_CR63","first-page":"807","volume":"15","author":"CV Oddis","year":"1988","unstructured":"Oddis CV, Medsger Jr TA. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis. J Rheumatol. 1988;15:807\u201311.","journal-title":"J Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0249-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-012-0249-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0249-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T05:18:08Z","timestamp":1561439888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-012-0249-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,13]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s11926-012-0249-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,13]]}}}